These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
181 related articles for article (PubMed ID: 21947960)
1. Proteomic analyses of Sirt1-mediated cisplatin resistance in OSCC cell line. Xiong P; Li YX; Tang YT; Chen HG Protein J; 2011 Oct; 30(7):499-508. PubMed ID: 21947960 [TBL] [Abstract][Full Text] [Related]
2. Up-regulation of TNF-alpha/NFkB/SIRT1 axis drives aggressiveness and cancer stem cells accumulation in chemoresistant oral squamous cell carcinoma. de Castro LR; de Oliveira LD; Milan TM; Eskenazi APE; Bighetti-Trevisan RL; de Almeida OGG; Amorim MLM; Squarize CH; Castilho RM; de Almeida LO J Cell Physiol; 2024 Feb; 239(2):e31164. PubMed ID: 38149816 [TBL] [Abstract][Full Text] [Related]
3. LncRNA UCA1 promotes proliferation and cisplatin resistance of oral squamous cell carcinoma by sunppressing miR-184 expression. Fang Z; Zhao J; Xie W; Sun Q; Wang H; Qiao B Cancer Med; 2017 Dec; 6(12):2897-2908. PubMed ID: 29125238 [TBL] [Abstract][Full Text] [Related]
4. WP1066 sensitizes oral squamous cell carcinoma cells to cisplatin by targeting STAT3/miR-21 axis. Zhou X; Ren Y; Liu A; Jin R; Jiang Q; Huang Y; Kong L; Wang X; Zhang L Sci Rep; 2014 Dec; 4():7461. PubMed ID: 25514838 [TBL] [Abstract][Full Text] [Related]
5. LncRNA HOXA11-AS Promotes Proliferation and Cisplatin Resistance of Oral Squamous Cell Carcinoma by Suppression of miR-214-3p Expression. Wang X; Li H; Shi J Biomed Res Int; 2019; 2019():8645153. PubMed ID: 31275988 [TBL] [Abstract][Full Text] [Related]
6. Exosomes containing miR-21 transfer the characteristic of cisplatin resistance by targeting PTEN and PDCD4 in oral squamous cell carcinoma. Liu T; Chen G; Sun D; Lei M; Li Y; Zhou C; Li X; Xue W; Wang H; Liu C; Xu J Acta Biochim Biophys Sin (Shanghai); 2017 Sep; 49(9):808-816. PubMed ID: 28910982 [TBL] [Abstract][Full Text] [Related]
7. Markedly increased Oct4 and Nanog expression correlates with cisplatin resistance in oral squamous cell carcinoma. Tsai LL; Yu CC; Chang YC; Yu CH; Chou MY J Oral Pathol Med; 2011 Sep; 40(8):621-8. PubMed ID: 21342274 [TBL] [Abstract][Full Text] [Related]
9. MiR-132 inhibits migration and invasion and increases chemosensitivity of cisplatin-resistant oral squamous cell carcinoma cells via targeting TGF-β1. Chen L; Zhu Q; Lu L; Liu Y Bioengineered; 2020 Dec; 11(1):91-102. PubMed ID: 31906769 [TBL] [Abstract][Full Text] [Related]
10. Silencing of GLUT-1 inhibits sensitization of oral cancer cells to cisplatin during hypoxia. Shimanishi M; Ogi K; Sogabe Y; Kaneko T; Dehari H; Miyazaki A; Hiratsuka H J Oral Pathol Med; 2013 May; 42(5):382-8. PubMed ID: 23227892 [TBL] [Abstract][Full Text] [Related]
11. Long noncoding RNA CEBPA-DT promotes cisplatin chemo-resistance through CEBPA/BCL2 mediated apoptosis in oral squamous cellular cancer. Qiao X; Liu J; Zhu L; Song R; Zhong M; Guo Y Int J Med Sci; 2021; 18(16):3728-3737. PubMed ID: 34790046 [TBL] [Abstract][Full Text] [Related]
12. Identification of genes associated with cisplatin resistance in human oral squamous cell carcinoma cell line. Zhang P; Zhang Z; Zhou X; Qiu W; Chen F; Chen W BMC Cancer; 2006 Sep; 6():224. PubMed ID: 16978399 [TBL] [Abstract][Full Text] [Related]
13. Long non-coding RNA CASC2 enhances cisplatin sensitivity in oral squamous cell cancer cells by the miR-31-5p/KANK1 axis. Wang J; Jia J; Zhou L Neoplasma; 2020 Nov; 67(6):1279-1292. PubMed ID: 32787433 [TBL] [Abstract][Full Text] [Related]
14. Effect of TET1 regulating MGMT on chemotherapy resistance of oral squamous cell carcinoma stem cells. Wang W; Li X; Wang F; Sun XY J Cell Biochem; 2018 Jan; 119(1):723-735. PubMed ID: 28643947 [TBL] [Abstract][Full Text] [Related]
15. Cisplatin-induced programmed cell death ligand-2 expression is associated with metastasis ability in oral squamous cell carcinoma. Sudo S; Kajiya H; Okano S; Sasaki M; Katsumata Y; Ohno J; Ikebe T; Hiraki A; Okabe K Cancer Sci; 2020 Apr; 111(4):1113-1123. PubMed ID: 32012401 [TBL] [Abstract][Full Text] [Related]
16. Bcl-xL expression and regulation in the progression, recurrence, and cisplatin resistance of oral cancer. Alam M; Mishra R Life Sci; 2021 Sep; 280():119705. PubMed ID: 34111459 [TBL] [Abstract][Full Text] [Related]
17. p22phox confers resistance to cisplatin, by blocking its entry into the nucleus. Hung CC; Chien CY; Chiang WF; Lin CS; Hour TC; Chen HR; Wang LF; Ko JY; Chang CH; Chen JY Oncotarget; 2015 Feb; 6(6):4110-25. PubMed ID: 25686830 [TBL] [Abstract][Full Text] [Related]
18. Knockdown of KPNA2 inhibits autophagy in oral squamous cell carcinoma cell lines by blocking p53 nuclear translocation. Lin F; Gao L; Su Z; Cao X; Zhan Y; Li Y; Zhang B Oncol Rep; 2018 Jul; 40(1):179-194. PubMed ID: 29781035 [TBL] [Abstract][Full Text] [Related]
19. miR-21 inhibitor sensitizes human OSCC cells to cisplatin. Wang W; Songlin P; Sun Y; Zhang B; Jinhui W Mol Biol Rep; 2012 May; 39(5):5481-5. PubMed ID: 22249446 [TBL] [Abstract][Full Text] [Related]
20. Chromatin remodeling-driven autophagy activation induces cisplatin resistance in oral squamous cell carcinoma. Oh SY; Kim J; Lee KY; Lee HJ; Kwon TG; Kim JW; Lee ST; Kim DG; Choi SY; Hong SH Cell Death Dis; 2024 Aug; 15(8):589. PubMed ID: 39138148 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]